IMMVF (Immunovia AB) E10: $-0.24 (As of Mar. 2026)


IMMVF Immunovia AB IMMVF
43 GF Score
Price $0.02
GF Value $0.01
! 4 Warning Signs
View Full Analysis

What is Immunovia AB E10?

Immunovia AB IMMVF -61.59% 43 E10 is $-0.24 as of Mar. 2026. GuruFocus rates IMMVF with a GF Score™ of 43/100 and a GF Value™ of $0.01. The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Immunovia AB's adjusted earnings per share data for the three months ended in Mar. 2026 was $-0.003. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $-0.24 for the trailing ten years ended in Mar. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2026-07-01), Immunovia AB's current stock price is $0.02. Immunovia AB's E10 for the quarter that ended in Mar. 2026 was $-0.24. Immunovia AB's Shiller PE Ratio of today is .


Immunovia AB  (OTCPK:IMMVF) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Immunovia AB E10 Related Terms


Immunovia AB E10 Historical Data

* Premium members only.

The historical data trend for Immunovia AB's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Immunovia AB E10 Chart

Immunovia AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 -0.28 -0.18

Immunovia AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.55 -0.36 -0.29 -0.18 -0.24

IMMVF vs TMO, DHR, IDXX: E10 Comparison

For the Diagnostics & Research subindustry, Immunovia AB's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Immunovia AB Shiller PE Ratio vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Immunovia AB's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Immunovia AB's Shiller PE Ratio falls into.


IMMVF
43GF Score
Immunovia AB IMMVF
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Immunovia AB E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Immunovia AB's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-0.003/133.3862*133.3862
=-0.003

Current CPI (Mar. 2026) = 133.3862.

Immunovia AB Quarterly Data

per share eps CPI Adj_EPS
201606 -0.009 101.019 -0.012
201609 -0.012 101.138 -0.016
201612 -0.013 102.022 -0.017
201703 -0.018 102.022 -0.024
201706 -0.026 102.752 -0.034
201709 -0.031 103.279 -0.040
201712 -0.038 103.793 -0.049
201803 -0.044 103.962 -0.056
201806 -0.060 104.875 -0.076
201809 -0.036 105.679 -0.045
201812 -0.053 105.912 -0.067
201903 -0.052 105.886 -0.066
201906 -0.058 106.742 -0.072
201909 -0.048 107.214 -0.060
201912 -0.063 107.766 -0.078
202003 -0.051 106.563 -0.064
202006 -0.064 107.498 -0.079
202009 -0.068 107.635 -0.084
202012 -0.088 108.296 -0.108
202103 -0.044 108.360 -0.054
202106 -0.093 108.928 -0.114
202109 -0.066 110.338 -0.080
202112 -0.082 112.486 -0.097
202203 -0.079 114.825 -0.092
202206 -0.057 118.384 -0.064
202209 -0.036 122.296 -0.039
202212 -0.091 126.365 -0.096
202303 -0.084 127.042 -0.088
202306 -0.143 129.407 -0.147
202309 -0.064 130.224 -0.066
202312 -0.082 131.912 -0.083
202403 -0.005 132.205 -0.005
202406 -0.042 132.716 -0.042
202409 -0.043 132.304 -0.043
202412 0.002 132.987 0.002
202503 -0.018 132.825 -0.018
202506 -0.011 133.699 -0.011
202509 -0.008 133.482 -0.008
202512 -0.003 133.386 -0.003
202603 -0.003 133.386 -0.003

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of $-0.24 mean?
Immunovia AB (IMMVF) has a E10 of $-0.24 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Immunovia AB and its competitors.
Is Immunovia AB's E10 too high?
Immunovia AB's current E10 is $-0.24. Overall, Immunovia AB has a GF Score™ of 43/100, reflecting its overall financial health beyond just this single metric.
How does Immunovia AB's E10 compare to TMO and DHR?
Immunovia AB's E10 of $-0.24 can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Medical Diagnostics & Research company?
A good E10 depends on the Medical Diagnostics & Research industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Immunovia AB and its competitors. Immunovia AB's current E10 is $-0.24. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Immunovia AB stock overvalued right now?
Immunovia AB (IMMVF) has a current E10 of $-0.24. The stock's GF Value™ is $0.01, compared to a current price of $0.02 — trading 100% above its estimated fair value. The current E10 is $-0.24. Immunovia AB's overall GF Score™ is 43/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Immunovia AB (IMMVF), the current E10 is $-0.24 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Immunovia AB (IMMVF) Overvalued in 2026?

Based on GuruFocus' analysis, Immunovia AB stock appears to be overvalued. The current stock price of $0.02 is trading 100% above its estimated GF Value™ of $0.01.

Key valuation signals for IMMVF:

  • E10: $-0.24
  • GF Value™: $0.01 vs. price of $0.02 (100% above fair value)
  • GF Score™: 43/100 with 4 warning signs

No single metric tells the full story. See the IMMVF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Immunovia AB Business Description

Other Exchanges IMMNOV:Sweden0G8X:UK
Address Scheelevagen 8, Medicon Village, Lund, SWE, 223 63
Immunovia AB is a diagnostic company. The company develops and commercializes diagnostic tools to detect proteins and autoimmune diseases. The company is developing its next-generation blood test to detect pancreatic cancer in high-risk individuals. IMMray platform is dedicated to the early detection of pancreatic cancer. Its technology platform IMMray (TM), is based on antibody microarray analysis.
43GF Score

Get the complete analysis for IMMVF

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.02
Price
$0.01
GF Value